The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients

Glucagon-like peptide-1 receptor agonists (GLP1RA) have been shown to improve glucose control and diabetes-related comorbidities in patients without solid organ transplants. The effectiveness, safety, and tolerability of GLP1RA after kidney transplantation have not been adequately studied. METHODS....

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Transplant Direct
Huvudupphovsmän: Kukla, Aleksandra, Hill, Jennifer, Merzkani, Massini, Bentall, Andrew, Lorenz, Elizabeth C., Park, Walter D., D’Costa, Matthew, Kudva, Yogish C., Stegall, Mark D., Shah, Pankaj
Materialtyp: Artigo
Språk:Inglês
Publicerad: Wolters Kluwer Health 2020
Ämnen:
Kidney Transplantation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004635/
https://ncbi.nlm.nih.gov/pubmed/32095510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000971
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk